Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Interest Expenses (2021 - 2025)

PAVmed (PAVM) has 5 years of Interest Expenses data on record, last reported at -$4000.0 in Q3 2025.

  • For Q3 2025, Interest Expenses changed N/A year-over-year to -$4000.0; the TTM value through Sep 2025 reached $33000.0, changed N/A, while the annual FY2024 figure was $45000.0, 92.36% down from the prior year.
  • Interest Expenses reached -$4000.0 in Q3 2025 per PAVM's latest filing, down from $26000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $526000.0 in Q3 2022 and bottomed at -$4000.0 in Q3 2025.
  • Average Interest Expenses over 5 years is $108538.5, with a median of $19000.0 recorded in 2023.
  • Peak YoY movement for Interest Expenses: tumbled 95.18% in 2024, then skyrocketed 136.36% in 2025.
  • A 5-year view of Interest Expenses shows it stood at $4000.0 in 2021, then skyrocketed by 5700.0% to $232000.0 in 2022, then tumbled by 91.81% to $19000.0 in 2023, then crashed by 63.16% to $7000.0 in 2024, then plummeted by 157.14% to -$4000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were -$4000.0 in Q3 2025, $26000.0 in Q2 2025, and $4000.0 in Q1 2025.